This study focuses on the development of theranostic, dual drug-loaded nanocarriers to propose a proof-of-principle therapeutic approach in treatment pancreatic ductal adenocarcinoma (PDAC). The nanoconstructs consist core zinc oxide nanocrystals doped with gadolinium, useful as potential contrast agent magnetic resonance imaging applications. After functionalizing their surface amino-propyl gr...